Millennium Management
NMTC icon

Millennium Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Millennium Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,475
Closed -$29K – 7293
2021
Q4 		$29K Sell
2,475
-15,217
-86% -$246K ﹤0.01% 6571
2021
Q3 		$419K Buy
+17,692
New +$508K ﹤0.01% 5506

Other funds holding NMTC

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DWM
Drive Wealth Management Lehi, Utah $561M AUM 33.14% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Millennium Management's NMTC Position: Q1 2022 in Review

Millennium Management sold out of NeuroOne Medical Technologies (NMTC) in Q1 2022, closing a stake of 2,475 shares — an estimated $29K sold.

Millennium Management first reported a position in NMTC in Q3 2021 and held it in 2 quarters. The position peaked at $419K in Q3 2021. 11 funds tracked by Wall St. Rank hold NMTC as of Q1 2022.

  • Millennium Management reported no remaining NeuroOne Medical Technologies position as of Q1 2022 after selling out during the quarter.
  • Millennium Management sold 2,475 NeuroOne Medical Technologies shares in Q1 2022, an estimated $29K.
  • Millennium Management first reported a position in NeuroOne Medical Technologies in Q3 2021 and held it in 2 quarters.
  • Millennium Management's NeuroOne Medical Technologies position peaked at $419K in Q3 2021.
  • 11 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.